Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with 11 C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging
Authors:
- 1 January 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 197 (1) , 129-134
Abstract
We identify sites and patterns of cancer recurrence in patients with post-prostatectomy biochemical relapse using 11C-choline positron emission tomography/computerized tomography and endorectal coil multiparametric magnetic resonance imaging. Between January 2008 and June 2015, 2,466 men underwent choline positron emission tomography for suspected prostate cancer relapse at our institution. Of these men 202 did not receive hormone or radiation therapy, underwent imaging with choline positron emission tomography and multiparametric magnetic resonance imaging, and were found to have disease recurrence. Overall patterns of recurrence were described, and factors associated with local only recurrence were evaluated using univariable and multivariable logistic regression. Median prostate specific antigen at positive scan was 2.3 ng/ml (IQR 1.4-5.5) with a median time from prostate specific antigen relapse to lesion visualization of 15 months (IQR 4.8-34.2). Of these 202 men 68 (33%) exhibited local only, 45 (22%) local plus metastatic and 89 (45%) metastatic only relapse. Pelvic node only relapse was observed in 39 (19%) men. Median prostate specific antigen at positive imaging for patients with local only, metastatic only and local plus metastatic relapse was 2.3, 2.7 and 2.2 ng/ml (p=0.46), with a median interval from biochemical recurrence to positive scan of 33.5, 7.0 and 15.0 months, respectively (p <0.001). On multivariable analysis time from biochemical recurrence to positive imaging was independently associated with local only recurrence (OR 1.10 for every 6-month increase, p=0.012). Combined choline positron emission tomography and multiparametric magnetic resonance imaging evaluation of biochemical recurrence after prostatectomy reveals an anatomically diverse pattern of recurrence. These findings have implications for optimizing the salvage treatment of patients with prostate cancer with relapse following surgery.Keywords
This publication has 23 references indexed in Scilit:
- Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline EndorsementJournal of Clinical Oncology, 2014
- Long-Term Outcomes After High-Dose Postprostatectomy Salvage Radiation TreatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical ProstatectomyJournal of Clinical Oncology, 2007
- Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostateRadiotherapy and Oncology, 2001
- Prediction of Response to Salvage Radiation Therapy in Patients With Prostate Cancer Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2001
- Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 yearsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARSJournal of Urology, 2000
- RADIOTHERAPY FOR ISOLATED SERUM PROSTATE SPECIFIC ANTIGEN ELEVATION AFTER PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999